Showing posts with label cell. Show all posts
Showing posts with label cell. Show all posts

Friday, July 24, 2009

Is FDA Watching Over Cell Phones as Medical Devices?

Updated March 24, 2021

People also search for the:

---  original post follows below  ---

Lately at work I've been noticing some buzz about mHealth, mobile health. The intersection of mHealth, cell phones, and FDA regulation of medical devices seems to be happening, reports this Bob on Medical Device Software post, When Cell Phones Become Medical Devices. According to the post:
Mobile devices are quickly becoming the conduit of choice for collecting and disseminating clinical data. The FDA will soon be forced to step in and take regulatory control. It’s going to happen eventually.
In a nutshell, it's time to start watching this, and paying attention to the possibility of having to follow FDA medical device regulations.  

Saturday, June 6, 2009

The HappyHour Gene - Implications for drinkers

This is an interesting read. University of California, San Francisco scientists have discovered the 'HappyHour' gene, a newly identified gene that makes fruit flies sensitive to booze. This means that drugs that mimic the effects of the gene may offer a new treatment against alcohol abuse. In this NewScientist article, 'Happyhour' gene may help put boozers off their drink, folks say, "People who are very sensitive to alcohol tend to drink less – that's the person who gets drunk on one glass of wine," and "The person who can drink everybody under the table – that's the person who is more likely to become an alcoholic." "Theoretically, a medication that increases the sensitivity to alcohol – that you need to drink less of to get an effect – might be protective," Heberlein says. Read Heberlein's findings in, Cell (DOI: 10.1016/j.ajhg.2009.04.018) - or the Research Abstract



Sunday, January 25, 2009

Wow - FDA OKs Stem Cell Trial - This is a red letter day!

I'm thrilled to see some momentum gaining in this potentially rich area of clinical research. The U.S. Food and Drug Administration has granted clearance for Geron Corp. to begin trials for the world's first study of a human embryonic stem cell-based therapy for people. Geron said it will begin a Phase I multicenter trial designed to establish the safety of its treatment, currently referred to as "GRNOPC1," in patients with complete Grade A subacute thoracic spinal cord injuries. Read more details in this Medical News Today article, US Approves First Trial Of Embryonic Stem Cells.

I'm of the opinion that stem cell research has been stifled for way too long, and it's good to see the appearance of these studies. What's your opinion?

Return Home: http://drughealth.blogspot.com/
The Health, Drug, Prescription, and GMP Supersite Gift Store
Return to Mobile Home: http://drughealth.mofuse.mobi/

From SkillsPlus International Inc.